サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1786682

E型肝炎診断検査の世界市場

Hepatitis E Diagnostic Tests

出版日
ページ情報
英文 285 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=148.66円
E型肝炎診断検査の世界市場
出版日: 2025年08月08日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 285 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

E型肝炎診断検査の世界市場は2030年までに6,780万米ドルに達する見込み

2024年に5,540万米ドルと推定されるE型肝炎診断検査の世界市場は、分析期間2024-2030年にCAGR 3.4%で成長し、2030年には6,780万米ドルに達すると予測されます。本レポートで分析したセグメントの1つであるELISA HEV IGM検査タイプは、CAGR 4.8%を記録し、分析期間終了までに2,960万米ドルに達すると予測されます。ELISA HEV IGG Tests Typeセグメントの成長率は、分析期間中CAGR 2.1%と推定されます。

米国市場は1,510万米ドルと推定される一方、中国はCAGR 6.6％で成長すると予測される

米国のE型肝炎診断検査市場は、2024年に1,510万米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに1,370万米ドルの市場規模に達すると予測され、分析期間2024-2030年のCAGRは6.6%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ1.3％と2.7％と予測されています。欧州では、ドイツがCAGR 2.0%で成長すると予測されています。

世界のE型肝炎診断検査市場- 主要動向と促進要因まとめ

E型肝炎診断が世界的に注目される理由とは？

E型肝炎ウイルス（HEV）による肝臓感染症であるE型肝炎は、清潔な水や衛生設備へのアクセスが限られている発展途上地域を中心に、公衆衛生上の懸念が高まっています。この病気は主に汚染された水源を通じて広がるため、インフラの整っていない国々では大きな課題となっています。診断検査は、HEV感染を検出し、タイムリーな治療を促進し、アウトブレイクを予防する上で重要な役割を果たします。流行地域でも非流行地域でもE型肝炎の流行が拡大しているため、正確で迅速な診断ソリューションに対する需要が高まっています。政府やヘルスケア機関は、HEVの蔓延を緩和するためにスクリーニングプログラムに投資しており、E型肝炎診断検査市場の拡大を牽引しています。

技術革新はE型肝炎診断をどのように改善しているか？

E型肝炎診断市場は、血清学的アッセイ、ポリメラーゼ連鎖反応（PCR）技術、ポイントオブケア検査ソリューションの改善により、急速な技術進歩を目の当たりにしています。酵素結合免疫吸着測定法（ELISA）の開発により、HEV抗体の検出精度と効率が向上し、早期診断と疾患モニタリングが可能になりました。さらに、リアルタイムPCRなどの分子診断技術の導入により、HEV RNAの正確な同定が可能になり、急性感染と慢性感染の鑑別に役立っています。迅速検査キットの登場は、特に資源が限られた環境におけるE型肝炎診断へのアクセスをさらに向上させています。このような技術革新により、E型肝炎検査の信頼性とアクセシビリティが向上し、疾病管理の改善に貢献しています。

なぜE型肝炎診断検査の需要が増加しているのか？

E型肝炎の罹患率の上昇、世界の渡航者の増加、ウイルス性肝炎に対する意識の高まりが、E型肝炎診断検査の需要に拍車をかけています。政府やヘルスケア機関は、HEV感染に伴う合併症を予防するため、妊婦や免疫不全者などのハイリスク集団にスクリーニングプログラムを実施しています。また、農村部におけるポイントオブケア診断の拡大も、疾病の発見と管理の改善に寄与しています。さらに、診断の自動化の進展により所要時間が短縮され、臨床現場での迅速な意思決定が可能となっています。世界の保健機関が肝炎の予防と制圧を優先する中、HEV診断ソリューションの需要は大きく伸びると予想されます。

E型肝炎診断検査市場の成長を促進する主な要因は？

E型肝炎診断検査市場の成長は、疾患有病率の増加、診断技術の進歩、ウイルス性肝炎サーベイランスの改善を目的とした政府のイニシアチブによってもたらされます。また、新興諸国におけるヘルスケアインフラの拡大も、肝炎検査へのアクセス拡大を促進しています。さらに、より迅速で正確な診断ソリューションの研究開発への投資が増加していることも、市場の成長に寄与しています。公衆衛生戦略がウイルス性肝炎の早期発見と予防に重点を置いていることから、E型肝炎診断検査市場は大幅な拡大が見込まれています。

セグメント

タイプ（ELISA HEV IGM検査タイプ、ELISA HEV IGG検査タイプ、迅速診断検査タイプ、ポリメラーゼ連鎖反応タイプ）、エンドユーザー（病院エンドユーザー、診断研究所エンドユーザー、血液銀行エンドユーザー、その他エンドユーザー）

調査対象企業の例

  • Altona Diagnostics GmbH
  • Beijing Beier Bioengineering Co., Ltd.
  • Beijing Zhongjian Antai Diagnosis Technology Co., Ltd.
  • CTK Biotech, Inc.
  • Dia.Pro Diagnostic Bioprobes s.r.l
  • DiaSorin S.p.A.
  • ELITechGroup
  • Eurofins Viracor
  • F. Hoffmann-La Roche Ltd
  • Fortress Diagnostics
  • GenScript Biotech Corporation
  • Guangzhou Wondfo Biotech Co., Ltd.
  • Healgen Scientific
  • Jiangsu Macro micro-test Medical Technology
  • Medsource Ozone Biomedicals Pvt. Ltd.
  • Mikrogen GmbH
  • MP Biomedicals
  • PerkinElmer, Inc.
  • Primerdesign Ltd
  • Wantai BioPharm

AIインテグレーション

Global Industry Analystsは、有効な専門家コンテンツとAIツールによって、市場情報と競合情報を変革しています。

Global Industry Analystsは、LLMや業界固有のSLMを照会する一般的な規範に従う代わりに、ビデオ記録、ブログ、検索エンジン調査、膨大な量の企業、製品/サービス、市場データなど、世界中の専門家からキュレートされたコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • スペイン
  • ロシア
  • その他欧州
  • アジア太平洋
  • オーストラリア
  • インド
  • 韓国
  • その他アジア太平洋地域
  • ラテンアメリカ
  • アルゼンチン
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
  • 中東
  • イラン
  • イスラエル
  • サウジアラビア
  • アラブ首長国連邦
  • その他中東
  • アフリカ

第4章 競合

目次
Product Code: MCP31352

Global Hepatitis E Diagnostic Tests Market to Reach US$67.8 Million by 2030

The global market for Hepatitis E Diagnostic Tests estimated at US$55.4 Million in the year 2024, is expected to reach US$67.8 Million by 2030, growing at a CAGR of 3.4% over the analysis period 2024-2030. ELISA HEV IGM Tests Type, one of the segments analyzed in the report, is expected to record a 4.8% CAGR and reach US$29.6 Million by the end of the analysis period. Growth in the ELISA HEV IGG Tests Type segment is estimated at 2.1% CAGR over the analysis period.

The U.S. Market is Estimated at US$15.1 Million While China is Forecast to Grow at 6.6% CAGR

The Hepatitis E Diagnostic Tests market in the U.S. is estimated at US$15.1 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$13.7 Million by the year 2030 trailing a CAGR of 6.6% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.3% and 2.7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.0% CAGR.

Global Hepatitis E Diagnostic Tests Market - Key Trends & Drivers Summarized

Why Is Hepatitis E Diagnosis Gaining Global Attention?

Hepatitis E, a liver infection caused by the hepatitis E virus (HEV), is becoming an increasing public health concern, particularly in developing regions with limited access to clean water and sanitation. The disease primarily spreads through contaminated water sources, making it a significant challenge in countries with poor infrastructure. Diagnostic tests play a crucial role in detecting HEV infections, facilitating timely treatment, and preventing outbreaks. The growing prevalence of hepatitis E in both endemic and non-endemic regions has heightened the demand for accurate and rapid diagnostic solutions. Governments and healthcare organizations are investing in screening programs to mitigate the spread of HEV, driving the expansion of the hepatitis E diagnostic tests market.

How Are Technological Innovations Improving Hepatitis E Diagnostics?

The hepatitis E diagnostic market is witnessing rapid technological advancements, with improvements in serological assays, polymerase chain reaction (PCR) techniques, and point-of-care testing solutions. The development of enzyme-linked immunosorbent assays (ELISA) has enhanced the accuracy and efficiency of detecting HEV antibodies, allowing for early diagnosis and disease monitoring. Additionally, the introduction of molecular diagnostic techniques, such as real-time PCR, has enabled precise identification of HEV RNA, aiding in the differentiation of acute and chronic infections. The emergence of rapid test kits is further improving access to hepatitis E diagnostics, particularly in resource-limited settings. These innovations are enhancing the reliability and accessibility of hepatitis E testing, contributing to improved disease control efforts.

Why Is the Demand for Hepatitis E Diagnostic Tests Increasing?

The rising incidence of hepatitis E infections, increasing global travel, and growing awareness about viral hepatitis have fueled the demand for hepatitis E diagnostic tests. Governments and healthcare agencies are implementing screening programs in high-risk populations, such as pregnant women and immunocompromised individuals, to prevent complications associated with HEV infections. The expansion of point-of-care diagnostics in rural areas has also contributed to improved disease detection and management. Additionally, advancements in diagnostic automation are reducing turnaround times, enabling faster decision-making in clinical settings. As global health organizations prioritize hepatitis prevention and control, the demand for HEV diagnostic solutions is expected to grow significantly.

What Are the Key Factors Driving the Growth of the Hepatitis E Diagnostic Tests Market?

The growth in the hepatitis E diagnostic tests market is driven by increasing disease prevalence, advancements in diagnostic technologies, and government initiatives aimed at improving viral hepatitis surveillance. The expansion of healthcare infrastructure in developing countries is also facilitating greater access to hepatitis testing. Additionally, the rising investment in research and development for faster and more accurate diagnostic solutions is contributing to market growth. As public health strategies focus on early detection and prevention of viral hepatitis, the hepatitis E diagnostic tests market is poised for substantial expansion.

SCOPE OF STUDY:

The report analyzes the Hepatitis E Diagnostic Tests market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Type (ELISA HEV IGM Tests Type, ELISA HEV IGG Tests Type, Rapid Diagnostics Tests Type, Polymerase Chain Reaction Type); End-Use (Hospitals End-Use, Diagnostics Laboratories End-Use, Blood Banks End-Use, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 42 Featured) -

  • Altona Diagnostics GmbH
  • Beijing Beier Bioengineering Co., Ltd.
  • Beijing Zhongjian Antai Diagnosis Technology Co., Ltd.
  • CTK Biotech, Inc.
  • Dia.Pro Diagnostic Bioprobes s.r.l
  • DiaSorin S.p.A.
  • ELITechGroup
  • Eurofins Viracor
  • F. Hoffmann-La Roche Ltd
  • Fortress Diagnostics
  • GenScript Biotech Corporation
  • Guangzhou Wondfo Biotech Co., Ltd.
  • Healgen Scientific
  • Jiangsu Macro micro-test Medical Technology
  • Medsource Ozone Biomedicals Pvt. Ltd.
  • Mikrogen GmbH
  • MP Biomedicals
  • PerkinElmer, Inc.
  • Primerdesign Ltd
  • Wantai BioPharm

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Hepatitis E Diagnostic Tests - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Incidence of Hepatitis E in Developing Regions Drives Demand for Diagnostic Tests
    • Technological Advancements in Molecular Diagnostics Strengthen the Business Case for Hepatitis E Testing
    • Increased Focus on Early Diagnosis of Hepatitis E to Prevent Outbreaks Spurs Growth in Diagnostic Market
    • Emergence of Rapid Testing Solutions Expands Addressable Market Opportunity for Hepatitis E Diagnostics
    • Regulatory Support for Hepatitis E Testing in Public Health Programs Accelerates Market Adoption
    • Growing Awareness About Hepatitis E in High-Risk Populations Drives Demand for Diagnostic Tools
    • Expansion of Hepatitis E Screening Programs in Endemic Regions Promotes Adoption of Diagnostic Tests
    • Integration of Hepatitis E Diagnostic Tests into Routine Healthcare Practices Generates Demand for Reliable Solutions
    • Healthcare Infrastructure Development in Emerging Markets Expands Market Opportunity for Hepatitis E Diagnostics
    • Increased Investment in Infectious Disease Diagnostics Spurs Growth in Hepatitis E Testing Solutions
    • The Shift Toward Point-of-Care Testing Solutions Drives Market Growth for Hepatitis E Diagnostics
    • Rising Government and NGO Efforts to Combat Hepatitis E Promote Widespread Use of Diagnostic Tests
    • Advances in Immunoassay Technology Propel Innovation in Hepatitis E Diagnostic Testing
    • Growing Importance of Hepatitis E Diagnosis in Pregnancy and Transfusion Medicine Generates Market Opportunities
    • Improvement in Test Sensitivity and Specificity Strengthens the Case for Hepatitis E Diagnostic Kits
    • Integration of Hepatitis E Diagnostic Solutions with Digital Health Platforms Expands Adoption Across Healthcare Systems
    • The Emergence of Next-Generation Sequencing Technologies Spurs Growth in Molecular Hepatitis E Diagnostics
    • Collaborations Between Pharmaceutical Companies and Diagnostic Providers Strengthen Hepatitis E Test Market
    • Expanding Global Travel and Migration Trends Heighten the Need for Hepatitis E Screening and Diagnostics
    • The Push Toward Universal Health Coverage and Preventative Healthcare Drives Demand for Hepatitis E Testing
    • Rising Environmental and Sanitation Concerns Contribute to Increased Testing for Hepatitis E in Vulnerable Regions
    • The Development of Combination Diagnostic Panels for Hepatitis E and Other Hepatitis Viruses Promotes Market Expansion
    • Improved Government Funding and Initiatives to Combat Hepatitis E Accelerates Diagnostic Solutions Adoption
    • Enhanced Global Surveillance Systems for Hepatitis E Drives Innovation and Investment in Diagnostic Solutions
    • Growing Number of Hepatitis E Outbreaks Due to Climate Change Prompts Accelerated Demand for Diagnostic Tests
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Hepatitis E Diagnostic Tests Market Analysis of Annual Sales in US$ for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Hepatitis E Diagnostic Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Hepatitis E Diagnostic Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Hepatitis E Diagnostic Tests by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for ELISA HEV IGM Tests Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for ELISA HEV IGM Tests Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for ELISA HEV IGM Tests Type by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for ELISA HEV IGG Tests Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for ELISA HEV IGG Tests Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for ELISA HEV IGG Tests Type by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Rapid Diagnostics Tests Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Rapid Diagnostics Tests Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Rapid Diagnostics Tests Type by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Polymerase Chain Reaction Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Polymerase Chain Reaction Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Polymerase Chain Reaction Type by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Hospitals End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Diagnostics Laboratories End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Diagnostics Laboratories End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Diagnostics Laboratories End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Blood Banks End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Blood Banks End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Blood Banks End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Hepatitis E Diagnostic Tests Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 29: USA Recent Past, Current & Future Analysis for Hepatitis E Diagnostic Tests by Type - ELISA HEV IGM Tests Type, ELISA HEV IGG Tests Type, Rapid Diagnostics Tests Type and Polymerase Chain Reaction Type - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Hepatitis E Diagnostic Tests by Type - ELISA HEV IGM Tests Type, ELISA HEV IGG Tests Type, Rapid Diagnostics Tests Type and Polymerase Chain Reaction Type Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 31: USA 15-Year Perspective for Hepatitis E Diagnostic Tests by Type - Percentage Breakdown of Value Sales for ELISA HEV IGM Tests Type, ELISA HEV IGG Tests Type, Rapid Diagnostics Tests Type and Polymerase Chain Reaction Type for the Years 2015, 2025 & 2030
    • TABLE 32: USA Recent Past, Current & Future Analysis for Hepatitis E Diagnostic Tests by End-Use - Hospitals End-Use, Diagnostics Laboratories End-Use, Blood Banks End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for Hepatitis E Diagnostic Tests by End-Use - Hospitals End-Use, Diagnostics Laboratories End-Use, Blood Banks End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 34: USA 15-Year Perspective for Hepatitis E Diagnostic Tests by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostics Laboratories End-Use, Blood Banks End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 35: Canada Recent Past, Current & Future Analysis for Hepatitis E Diagnostic Tests by Type - ELISA HEV IGM Tests Type, ELISA HEV IGG Tests Type, Rapid Diagnostics Tests Type and Polymerase Chain Reaction Type - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Canada Historic Review for Hepatitis E Diagnostic Tests by Type - ELISA HEV IGM Tests Type, ELISA HEV IGG Tests Type, Rapid Diagnostics Tests Type and Polymerase Chain Reaction Type Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 37: Canada 15-Year Perspective for Hepatitis E Diagnostic Tests by Type - Percentage Breakdown of Value Sales for ELISA HEV IGM Tests Type, ELISA HEV IGG Tests Type, Rapid Diagnostics Tests Type and Polymerase Chain Reaction Type for the Years 2015, 2025 & 2030
    • TABLE 38: Canada Recent Past, Current & Future Analysis for Hepatitis E Diagnostic Tests by End-Use - Hospitals End-Use, Diagnostics Laboratories End-Use, Blood Banks End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Canada Historic Review for Hepatitis E Diagnostic Tests by End-Use - Hospitals End-Use, Diagnostics Laboratories End-Use, Blood Banks End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 40: Canada 15-Year Perspective for Hepatitis E Diagnostic Tests by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostics Laboratories End-Use, Blood Banks End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • JAPAN
    • Hepatitis E Diagnostic Tests Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 41: Japan Recent Past, Current & Future Analysis for Hepatitis E Diagnostic Tests by Type - ELISA HEV IGM Tests Type, ELISA HEV IGG Tests Type, Rapid Diagnostics Tests Type and Polymerase Chain Reaction Type - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Japan Historic Review for Hepatitis E Diagnostic Tests by Type - ELISA HEV IGM Tests Type, ELISA HEV IGG Tests Type, Rapid Diagnostics Tests Type and Polymerase Chain Reaction Type Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 43: Japan 15-Year Perspective for Hepatitis E Diagnostic Tests by Type - Percentage Breakdown of Value Sales for ELISA HEV IGM Tests Type, ELISA HEV IGG Tests Type, Rapid Diagnostics Tests Type and Polymerase Chain Reaction Type for the Years 2015, 2025 & 2030
    • TABLE 44: Japan Recent Past, Current & Future Analysis for Hepatitis E Diagnostic Tests by End-Use - Hospitals End-Use, Diagnostics Laboratories End-Use, Blood Banks End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Japan Historic Review for Hepatitis E Diagnostic Tests by End-Use - Hospitals End-Use, Diagnostics Laboratories End-Use, Blood Banks End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 46: Japan 15-Year Perspective for Hepatitis E Diagnostic Tests by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostics Laboratories End-Use, Blood Banks End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • CHINA
    • Hepatitis E Diagnostic Tests Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 47: China Recent Past, Current & Future Analysis for Hepatitis E Diagnostic Tests by Type - ELISA HEV IGM Tests Type, ELISA HEV IGG Tests Type, Rapid Diagnostics Tests Type and Polymerase Chain Reaction Type - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 48: China Historic Review for Hepatitis E Diagnostic Tests by Type - ELISA HEV IGM Tests Type, ELISA HEV IGG Tests Type, Rapid Diagnostics Tests Type and Polymerase Chain Reaction Type Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 49: China 15-Year Perspective for Hepatitis E Diagnostic Tests by Type - Percentage Breakdown of Value Sales for ELISA HEV IGM Tests Type, ELISA HEV IGG Tests Type, Rapid Diagnostics Tests Type and Polymerase Chain Reaction Type for the Years 2015, 2025 & 2030
    • TABLE 50: China Recent Past, Current & Future Analysis for Hepatitis E Diagnostic Tests by End-Use - Hospitals End-Use, Diagnostics Laboratories End-Use, Blood Banks End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 51: China Historic Review for Hepatitis E Diagnostic Tests by End-Use - Hospitals End-Use, Diagnostics Laboratories End-Use, Blood Banks End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 52: China 15-Year Perspective for Hepatitis E Diagnostic Tests by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostics Laboratories End-Use, Blood Banks End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • EUROPE
    • Hepatitis E Diagnostic Tests Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Hepatitis E Diagnostic Tests by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Hepatitis E Diagnostic Tests by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 55: Europe 15-Year Perspective for Hepatitis E Diagnostic Tests by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 56: Europe Recent Past, Current & Future Analysis for Hepatitis E Diagnostic Tests by Type - ELISA HEV IGM Tests Type, ELISA HEV IGG Tests Type, Rapid Diagnostics Tests Type and Polymerase Chain Reaction Type - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Europe Historic Review for Hepatitis E Diagnostic Tests by Type - ELISA HEV IGM Tests Type, ELISA HEV IGG Tests Type, Rapid Diagnostics Tests Type and Polymerase Chain Reaction Type Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 58: Europe 15-Year Perspective for Hepatitis E Diagnostic Tests by Type - Percentage Breakdown of Value Sales for ELISA HEV IGM Tests Type, ELISA HEV IGG Tests Type, Rapid Diagnostics Tests Type and Polymerase Chain Reaction Type for the Years 2015, 2025 & 2030
    • TABLE 59: Europe Recent Past, Current & Future Analysis for Hepatitis E Diagnostic Tests by End-Use - Hospitals End-Use, Diagnostics Laboratories End-Use, Blood Banks End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Europe Historic Review for Hepatitis E Diagnostic Tests by End-Use - Hospitals End-Use, Diagnostics Laboratories End-Use, Blood Banks End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 61: Europe 15-Year Perspective for Hepatitis E Diagnostic Tests by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostics Laboratories End-Use, Blood Banks End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • FRANCE
    • Hepatitis E Diagnostic Tests Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 62: France Recent Past, Current & Future Analysis for Hepatitis E Diagnostic Tests by Type - ELISA HEV IGM Tests Type, ELISA HEV IGG Tests Type, Rapid Diagnostics Tests Type and Polymerase Chain Reaction Type - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 63: France Historic Review for Hepatitis E Diagnostic Tests by Type - ELISA HEV IGM Tests Type, ELISA HEV IGG Tests Type, Rapid Diagnostics Tests Type and Polymerase Chain Reaction Type Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 64: France 15-Year Perspective for Hepatitis E Diagnostic Tests by Type - Percentage Breakdown of Value Sales for ELISA HEV IGM Tests Type, ELISA HEV IGG Tests Type, Rapid Diagnostics Tests Type and Polymerase Chain Reaction Type for the Years 2015, 2025 & 2030
    • TABLE 65: France Recent Past, Current & Future Analysis for Hepatitis E Diagnostic Tests by End-Use - Hospitals End-Use, Diagnostics Laboratories End-Use, Blood Banks End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 66: France Historic Review for Hepatitis E Diagnostic Tests by End-Use - Hospitals End-Use, Diagnostics Laboratories End-Use, Blood Banks End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 67: France 15-Year Perspective for Hepatitis E Diagnostic Tests by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostics Laboratories End-Use, Blood Banks End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • GERMANY
    • Hepatitis E Diagnostic Tests Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 68: Germany Recent Past, Current & Future Analysis for Hepatitis E Diagnostic Tests by Type - ELISA HEV IGM Tests Type, ELISA HEV IGG Tests Type, Rapid Diagnostics Tests Type and Polymerase Chain Reaction Type - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Germany Historic Review for Hepatitis E Diagnostic Tests by Type - ELISA HEV IGM Tests Type, ELISA HEV IGG Tests Type, Rapid Diagnostics Tests Type and Polymerase Chain Reaction Type Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 70: Germany 15-Year Perspective for Hepatitis E Diagnostic Tests by Type - Percentage Breakdown of Value Sales for ELISA HEV IGM Tests Type, ELISA HEV IGG Tests Type, Rapid Diagnostics Tests Type and Polymerase Chain Reaction Type for the Years 2015, 2025 & 2030
    • TABLE 71: Germany Recent Past, Current & Future Analysis for Hepatitis E Diagnostic Tests by End-Use - Hospitals End-Use, Diagnostics Laboratories End-Use, Blood Banks End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Germany Historic Review for Hepatitis E Diagnostic Tests by End-Use - Hospitals End-Use, Diagnostics Laboratories End-Use, Blood Banks End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 73: Germany 15-Year Perspective for Hepatitis E Diagnostic Tests by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostics Laboratories End-Use, Blood Banks End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 74: Italy Recent Past, Current & Future Analysis for Hepatitis E Diagnostic Tests by Type - ELISA HEV IGM Tests Type, ELISA HEV IGG Tests Type, Rapid Diagnostics Tests Type and Polymerase Chain Reaction Type - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Italy Historic Review for Hepatitis E Diagnostic Tests by Type - ELISA HEV IGM Tests Type, ELISA HEV IGG Tests Type, Rapid Diagnostics Tests Type and Polymerase Chain Reaction Type Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 76: Italy 15-Year Perspective for Hepatitis E Diagnostic Tests by Type - Percentage Breakdown of Value Sales for ELISA HEV IGM Tests Type, ELISA HEV IGG Tests Type, Rapid Diagnostics Tests Type and Polymerase Chain Reaction Type for the Years 2015, 2025 & 2030
    • TABLE 77: Italy Recent Past, Current & Future Analysis for Hepatitis E Diagnostic Tests by End-Use - Hospitals End-Use, Diagnostics Laboratories End-Use, Blood Banks End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Italy Historic Review for Hepatitis E Diagnostic Tests by End-Use - Hospitals End-Use, Diagnostics Laboratories End-Use, Blood Banks End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 79: Italy 15-Year Perspective for Hepatitis E Diagnostic Tests by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostics Laboratories End-Use, Blood Banks End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Hepatitis E Diagnostic Tests Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 80: UK Recent Past, Current & Future Analysis for Hepatitis E Diagnostic Tests by Type - ELISA HEV IGM Tests Type, ELISA HEV IGG Tests Type, Rapid Diagnostics Tests Type and Polymerase Chain Reaction Type - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 81: UK Historic Review for Hepatitis E Diagnostic Tests by Type - ELISA HEV IGM Tests Type, ELISA HEV IGG Tests Type, Rapid Diagnostics Tests Type and Polymerase Chain Reaction Type Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 82: UK 15-Year Perspective for Hepatitis E Diagnostic Tests by Type - Percentage Breakdown of Value Sales for ELISA HEV IGM Tests Type, ELISA HEV IGG Tests Type, Rapid Diagnostics Tests Type and Polymerase Chain Reaction Type for the Years 2015, 2025 & 2030
    • TABLE 83: UK Recent Past, Current & Future Analysis for Hepatitis E Diagnostic Tests by End-Use - Hospitals End-Use, Diagnostics Laboratories End-Use, Blood Banks End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 84: UK Historic Review for Hepatitis E Diagnostic Tests by End-Use - Hospitals End-Use, Diagnostics Laboratories End-Use, Blood Banks End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 85: UK 15-Year Perspective for Hepatitis E Diagnostic Tests by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostics Laboratories End-Use, Blood Banks End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 86: Spain Recent Past, Current & Future Analysis for Hepatitis E Diagnostic Tests by Type - ELISA HEV IGM Tests Type, ELISA HEV IGG Tests Type, Rapid Diagnostics Tests Type and Polymerase Chain Reaction Type - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Spain Historic Review for Hepatitis E Diagnostic Tests by Type - ELISA HEV IGM Tests Type, ELISA HEV IGG Tests Type, Rapid Diagnostics Tests Type and Polymerase Chain Reaction Type Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 88: Spain 15-Year Perspective for Hepatitis E Diagnostic Tests by Type - Percentage Breakdown of Value Sales for ELISA HEV IGM Tests Type, ELISA HEV IGG Tests Type, Rapid Diagnostics Tests Type and Polymerase Chain Reaction Type for the Years 2015, 2025 & 2030
    • TABLE 89: Spain Recent Past, Current & Future Analysis for Hepatitis E Diagnostic Tests by End-Use - Hospitals End-Use, Diagnostics Laboratories End-Use, Blood Banks End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Spain Historic Review for Hepatitis E Diagnostic Tests by End-Use - Hospitals End-Use, Diagnostics Laboratories End-Use, Blood Banks End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 91: Spain 15-Year Perspective for Hepatitis E Diagnostic Tests by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostics Laboratories End-Use, Blood Banks End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 92: Russia Recent Past, Current & Future Analysis for Hepatitis E Diagnostic Tests by Type - ELISA HEV IGM Tests Type, ELISA HEV IGG Tests Type, Rapid Diagnostics Tests Type and Polymerase Chain Reaction Type - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Russia Historic Review for Hepatitis E Diagnostic Tests by Type - ELISA HEV IGM Tests Type, ELISA HEV IGG Tests Type, Rapid Diagnostics Tests Type and Polymerase Chain Reaction Type Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 94: Russia 15-Year Perspective for Hepatitis E Diagnostic Tests by Type - Percentage Breakdown of Value Sales for ELISA HEV IGM Tests Type, ELISA HEV IGG Tests Type, Rapid Diagnostics Tests Type and Polymerase Chain Reaction Type for the Years 2015, 2025 & 2030
    • TABLE 95: Russia Recent Past, Current & Future Analysis for Hepatitis E Diagnostic Tests by End-Use - Hospitals End-Use, Diagnostics Laboratories End-Use, Blood Banks End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Russia Historic Review for Hepatitis E Diagnostic Tests by End-Use - Hospitals End-Use, Diagnostics Laboratories End-Use, Blood Banks End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 97: Russia 15-Year Perspective for Hepatitis E Diagnostic Tests by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostics Laboratories End-Use, Blood Banks End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 98: Rest of Europe Recent Past, Current & Future Analysis for Hepatitis E Diagnostic Tests by Type - ELISA HEV IGM Tests Type, ELISA HEV IGG Tests Type, Rapid Diagnostics Tests Type and Polymerase Chain Reaction Type - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Rest of Europe Historic Review for Hepatitis E Diagnostic Tests by Type - ELISA HEV IGM Tests Type, ELISA HEV IGG Tests Type, Rapid Diagnostics Tests Type and Polymerase Chain Reaction Type Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 100: Rest of Europe 15-Year Perspective for Hepatitis E Diagnostic Tests by Type - Percentage Breakdown of Value Sales for ELISA HEV IGM Tests Type, ELISA HEV IGG Tests Type, Rapid Diagnostics Tests Type and Polymerase Chain Reaction Type for the Years 2015, 2025 & 2030
    • TABLE 101: Rest of Europe Recent Past, Current & Future Analysis for Hepatitis E Diagnostic Tests by End-Use - Hospitals End-Use, Diagnostics Laboratories End-Use, Blood Banks End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Rest of Europe Historic Review for Hepatitis E Diagnostic Tests by End-Use - Hospitals End-Use, Diagnostics Laboratories End-Use, Blood Banks End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 103: Rest of Europe 15-Year Perspective for Hepatitis E Diagnostic Tests by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostics Laboratories End-Use, Blood Banks End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Hepatitis E Diagnostic Tests Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Hepatitis E Diagnostic Tests by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific Historic Review for Hepatitis E Diagnostic Tests by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 106: Asia-Pacific 15-Year Perspective for Hepatitis E Diagnostic Tests by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 107: Asia-Pacific Recent Past, Current & Future Analysis for Hepatitis E Diagnostic Tests by Type - ELISA HEV IGM Tests Type, ELISA HEV IGG Tests Type, Rapid Diagnostics Tests Type and Polymerase Chain Reaction Type - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Asia-Pacific Historic Review for Hepatitis E Diagnostic Tests by Type - ELISA HEV IGM Tests Type, ELISA HEV IGG Tests Type, Rapid Diagnostics Tests Type and Polymerase Chain Reaction Type Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 109: Asia-Pacific 15-Year Perspective for Hepatitis E Diagnostic Tests by Type - Percentage Breakdown of Value Sales for ELISA HEV IGM Tests Type, ELISA HEV IGG Tests Type, Rapid Diagnostics Tests Type and Polymerase Chain Reaction Type for the Years 2015, 2025 & 2030
    • TABLE 110: Asia-Pacific Recent Past, Current & Future Analysis for Hepatitis E Diagnostic Tests by End-Use - Hospitals End-Use, Diagnostics Laboratories End-Use, Blood Banks End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Asia-Pacific Historic Review for Hepatitis E Diagnostic Tests by End-Use - Hospitals End-Use, Diagnostics Laboratories End-Use, Blood Banks End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 112: Asia-Pacific 15-Year Perspective for Hepatitis E Diagnostic Tests by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostics Laboratories End-Use, Blood Banks End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Hepatitis E Diagnostic Tests Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 113: Australia Recent Past, Current & Future Analysis for Hepatitis E Diagnostic Tests by Type - ELISA HEV IGM Tests Type, ELISA HEV IGG Tests Type, Rapid Diagnostics Tests Type and Polymerase Chain Reaction Type - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Australia Historic Review for Hepatitis E Diagnostic Tests by Type - ELISA HEV IGM Tests Type, ELISA HEV IGG Tests Type, Rapid Diagnostics Tests Type and Polymerase Chain Reaction Type Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 115: Australia 15-Year Perspective for Hepatitis E Diagnostic Tests by Type - Percentage Breakdown of Value Sales for ELISA HEV IGM Tests Type, ELISA HEV IGG Tests Type, Rapid Diagnostics Tests Type and Polymerase Chain Reaction Type for the Years 2015, 2025 & 2030
    • TABLE 116: Australia Recent Past, Current & Future Analysis for Hepatitis E Diagnostic Tests by End-Use - Hospitals End-Use, Diagnostics Laboratories End-Use, Blood Banks End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Australia Historic Review for Hepatitis E Diagnostic Tests by End-Use - Hospitals End-Use, Diagnostics Laboratories End-Use, Blood Banks End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 118: Australia 15-Year Perspective for Hepatitis E Diagnostic Tests by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostics Laboratories End-Use, Blood Banks End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • INDIA
    • Hepatitis E Diagnostic Tests Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 119: India Recent Past, Current & Future Analysis for Hepatitis E Diagnostic Tests by Type - ELISA HEV IGM Tests Type, ELISA HEV IGG Tests Type, Rapid Diagnostics Tests Type and Polymerase Chain Reaction Type - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 120: India Historic Review for Hepatitis E Diagnostic Tests by Type - ELISA HEV IGM Tests Type, ELISA HEV IGG Tests Type, Rapid Diagnostics Tests Type and Polymerase Chain Reaction Type Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 121: India 15-Year Perspective for Hepatitis E Diagnostic Tests by Type - Percentage Breakdown of Value Sales for ELISA HEV IGM Tests Type, ELISA HEV IGG Tests Type, Rapid Diagnostics Tests Type and Polymerase Chain Reaction Type for the Years 2015, 2025 & 2030
    • TABLE 122: India Recent Past, Current & Future Analysis for Hepatitis E Diagnostic Tests by End-Use - Hospitals End-Use, Diagnostics Laboratories End-Use, Blood Banks End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 123: India Historic Review for Hepatitis E Diagnostic Tests by End-Use - Hospitals End-Use, Diagnostics Laboratories End-Use, Blood Banks End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 124: India 15-Year Perspective for Hepatitis E Diagnostic Tests by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostics Laboratories End-Use, Blood Banks End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 125: South Korea Recent Past, Current & Future Analysis for Hepatitis E Diagnostic Tests by Type - ELISA HEV IGM Tests Type, ELISA HEV IGG Tests Type, Rapid Diagnostics Tests Type and Polymerase Chain Reaction Type - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 126: South Korea Historic Review for Hepatitis E Diagnostic Tests by Type - ELISA HEV IGM Tests Type, ELISA HEV IGG Tests Type, Rapid Diagnostics Tests Type and Polymerase Chain Reaction Type Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 127: South Korea 15-Year Perspective for Hepatitis E Diagnostic Tests by Type - Percentage Breakdown of Value Sales for ELISA HEV IGM Tests Type, ELISA HEV IGG Tests Type, Rapid Diagnostics Tests Type and Polymerase Chain Reaction Type for the Years 2015, 2025 & 2030
    • TABLE 128: South Korea Recent Past, Current & Future Analysis for Hepatitis E Diagnostic Tests by End-Use - Hospitals End-Use, Diagnostics Laboratories End-Use, Blood Banks End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 129: South Korea Historic Review for Hepatitis E Diagnostic Tests by End-Use - Hospitals End-Use, Diagnostics Laboratories End-Use, Blood Banks End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 130: South Korea 15-Year Perspective for Hepatitis E Diagnostic Tests by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostics Laboratories End-Use, Blood Banks End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 131: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Hepatitis E Diagnostic Tests by Type - ELISA HEV IGM Tests Type, ELISA HEV IGG Tests Type, Rapid Diagnostics Tests Type and Polymerase Chain Reaction Type - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Rest of Asia-Pacific Historic Review for Hepatitis E Diagnostic Tests by Type - ELISA HEV IGM Tests Type, ELISA HEV IGG Tests Type, Rapid Diagnostics Tests Type and Polymerase Chain Reaction Type Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 133: Rest of Asia-Pacific 15-Year Perspective for Hepatitis E Diagnostic Tests by Type - Percentage Breakdown of Value Sales for ELISA HEV IGM Tests Type, ELISA HEV IGG Tests Type, Rapid Diagnostics Tests Type and Polymerase Chain Reaction Type for the Years 2015, 2025 & 2030
    • TABLE 134: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Hepatitis E Diagnostic Tests by End-Use - Hospitals End-Use, Diagnostics Laboratories End-Use, Blood Banks End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Rest of Asia-Pacific Historic Review for Hepatitis E Diagnostic Tests by End-Use - Hospitals End-Use, Diagnostics Laboratories End-Use, Blood Banks End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 136: Rest of Asia-Pacific 15-Year Perspective for Hepatitis E Diagnostic Tests by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostics Laboratories End-Use, Blood Banks End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Hepatitis E Diagnostic Tests Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 137: Latin America Recent Past, Current & Future Analysis for Hepatitis E Diagnostic Tests by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 138: Latin America Historic Review for Hepatitis E Diagnostic Tests by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 139: Latin America 15-Year Perspective for Hepatitis E Diagnostic Tests by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 140: Latin America Recent Past, Current & Future Analysis for Hepatitis E Diagnostic Tests by Type - ELISA HEV IGM Tests Type, ELISA HEV IGG Tests Type, Rapid Diagnostics Tests Type and Polymerase Chain Reaction Type - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Latin America Historic Review for Hepatitis E Diagnostic Tests by Type - ELISA HEV IGM Tests Type, ELISA HEV IGG Tests Type, Rapid Diagnostics Tests Type and Polymerase Chain Reaction Type Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 142: Latin America 15-Year Perspective for Hepatitis E Diagnostic Tests by Type - Percentage Breakdown of Value Sales for ELISA HEV IGM Tests Type, ELISA HEV IGG Tests Type, Rapid Diagnostics Tests Type and Polymerase Chain Reaction Type for the Years 2015, 2025 & 2030
    • TABLE 143: Latin America Recent Past, Current & Future Analysis for Hepatitis E Diagnostic Tests by End-Use - Hospitals End-Use, Diagnostics Laboratories End-Use, Blood Banks End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Latin America Historic Review for Hepatitis E Diagnostic Tests by End-Use - Hospitals End-Use, Diagnostics Laboratories End-Use, Blood Banks End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 145: Latin America 15-Year Perspective for Hepatitis E Diagnostic Tests by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostics Laboratories End-Use, Blood Banks End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 146: Argentina Recent Past, Current & Future Analysis for Hepatitis E Diagnostic Tests by Type - ELISA HEV IGM Tests Type, ELISA HEV IGG Tests Type, Rapid Diagnostics Tests Type and Polymerase Chain Reaction Type - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Argentina Historic Review for Hepatitis E Diagnostic Tests by Type - ELISA HEV IGM Tests Type, ELISA HEV IGG Tests Type, Rapid Diagnostics Tests Type and Polymerase Chain Reaction Type Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 148: Argentina 15-Year Perspective for Hepatitis E Diagnostic Tests by Type - Percentage Breakdown of Value Sales for ELISA HEV IGM Tests Type, ELISA HEV IGG Tests Type, Rapid Diagnostics Tests Type and Polymerase Chain Reaction Type for the Years 2015, 2025 & 2030
    • TABLE 149: Argentina Recent Past, Current & Future Analysis for Hepatitis E Diagnostic Tests by End-Use - Hospitals End-Use, Diagnostics Laboratories End-Use, Blood Banks End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Argentina Historic Review for Hepatitis E Diagnostic Tests by End-Use - Hospitals End-Use, Diagnostics Laboratories End-Use, Blood Banks End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 151: Argentina 15-Year Perspective for Hepatitis E Diagnostic Tests by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostics Laboratories End-Use, Blood Banks End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 152: Brazil Recent Past, Current & Future Analysis for Hepatitis E Diagnostic Tests by Type - ELISA HEV IGM Tests Type, ELISA HEV IGG Tests Type, Rapid Diagnostics Tests Type and Polymerase Chain Reaction Type - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Brazil Historic Review for Hepatitis E Diagnostic Tests by Type - ELISA HEV IGM Tests Type, ELISA HEV IGG Tests Type, Rapid Diagnostics Tests Type and Polymerase Chain Reaction Type Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 154: Brazil 15-Year Perspective for Hepatitis E Diagnostic Tests by Type - Percentage Breakdown of Value Sales for ELISA HEV IGM Tests Type, ELISA HEV IGG Tests Type, Rapid Diagnostics Tests Type and Polymerase Chain Reaction Type for the Years 2015, 2025 & 2030
    • TABLE 155: Brazil Recent Past, Current & Future Analysis for Hepatitis E Diagnostic Tests by End-Use - Hospitals End-Use, Diagnostics Laboratories End-Use, Blood Banks End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Brazil Historic Review for Hepatitis E Diagnostic Tests by End-Use - Hospitals End-Use, Diagnostics Laboratories End-Use, Blood Banks End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 157: Brazil 15-Year Perspective for Hepatitis E Diagnostic Tests by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostics Laboratories End-Use, Blood Banks End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 158: Mexico Recent Past, Current & Future Analysis for Hepatitis E Diagnostic Tests by Type - ELISA HEV IGM Tests Type, ELISA HEV IGG Tests Type, Rapid Diagnostics Tests Type and Polymerase Chain Reaction Type - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Mexico Historic Review for Hepatitis E Diagnostic Tests by Type - ELISA HEV IGM Tests Type, ELISA HEV IGG Tests Type, Rapid Diagnostics Tests Type and Polymerase Chain Reaction Type Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 160: Mexico 15-Year Perspective for Hepatitis E Diagnostic Tests by Type - Percentage Breakdown of Value Sales for ELISA HEV IGM Tests Type, ELISA HEV IGG Tests Type, Rapid Diagnostics Tests Type and Polymerase Chain Reaction Type for the Years 2015, 2025 & 2030
    • TABLE 161: Mexico Recent Past, Current & Future Analysis for Hepatitis E Diagnostic Tests by End-Use - Hospitals End-Use, Diagnostics Laboratories End-Use, Blood Banks End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Mexico Historic Review for Hepatitis E Diagnostic Tests by End-Use - Hospitals End-Use, Diagnostics Laboratories End-Use, Blood Banks End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 163: Mexico 15-Year Perspective for Hepatitis E Diagnostic Tests by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostics Laboratories End-Use, Blood Banks End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 164: Rest of Latin America Recent Past, Current & Future Analysis for Hepatitis E Diagnostic Tests by Type - ELISA HEV IGM Tests Type, ELISA HEV IGG Tests Type, Rapid Diagnostics Tests Type and Polymerase Chain Reaction Type - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Rest of Latin America Historic Review for Hepatitis E Diagnostic Tests by Type - ELISA HEV IGM Tests Type, ELISA HEV IGG Tests Type, Rapid Diagnostics Tests Type and Polymerase Chain Reaction Type Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 166: Rest of Latin America 15-Year Perspective for Hepatitis E Diagnostic Tests by Type - Percentage Breakdown of Value Sales for ELISA HEV IGM Tests Type, ELISA HEV IGG Tests Type, Rapid Diagnostics Tests Type and Polymerase Chain Reaction Type for the Years 2015, 2025 & 2030
    • TABLE 167: Rest of Latin America Recent Past, Current & Future Analysis for Hepatitis E Diagnostic Tests by End-Use - Hospitals End-Use, Diagnostics Laboratories End-Use, Blood Banks End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Rest of Latin America Historic Review for Hepatitis E Diagnostic Tests by End-Use - Hospitals End-Use, Diagnostics Laboratories End-Use, Blood Banks End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 169: Rest of Latin America 15-Year Perspective for Hepatitis E Diagnostic Tests by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostics Laboratories End-Use, Blood Banks End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Hepatitis E Diagnostic Tests Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 170: Middle East Recent Past, Current & Future Analysis for Hepatitis E Diagnostic Tests by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 171: Middle East Historic Review for Hepatitis E Diagnostic Tests by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 172: Middle East 15-Year Perspective for Hepatitis E Diagnostic Tests by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 173: Middle East Recent Past, Current & Future Analysis for Hepatitis E Diagnostic Tests by Type - ELISA HEV IGM Tests Type, ELISA HEV IGG Tests Type, Rapid Diagnostics Tests Type and Polymerase Chain Reaction Type - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Middle East Historic Review for Hepatitis E Diagnostic Tests by Type - ELISA HEV IGM Tests Type, ELISA HEV IGG Tests Type, Rapid Diagnostics Tests Type and Polymerase Chain Reaction Type Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 175: Middle East 15-Year Perspective for Hepatitis E Diagnostic Tests by Type - Percentage Breakdown of Value Sales for ELISA HEV IGM Tests Type, ELISA HEV IGG Tests Type, Rapid Diagnostics Tests Type and Polymerase Chain Reaction Type for the Years 2015, 2025 & 2030
    • TABLE 176: Middle East Recent Past, Current & Future Analysis for Hepatitis E Diagnostic Tests by End-Use - Hospitals End-Use, Diagnostics Laboratories End-Use, Blood Banks End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Middle East Historic Review for Hepatitis E Diagnostic Tests by End-Use - Hospitals End-Use, Diagnostics Laboratories End-Use, Blood Banks End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 178: Middle East 15-Year Perspective for Hepatitis E Diagnostic Tests by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostics Laboratories End-Use, Blood Banks End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 179: Iran Recent Past, Current & Future Analysis for Hepatitis E Diagnostic Tests by Type - ELISA HEV IGM Tests Type, ELISA HEV IGG Tests Type, Rapid Diagnostics Tests Type and Polymerase Chain Reaction Type - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Iran Historic Review for Hepatitis E Diagnostic Tests by Type - ELISA HEV IGM Tests Type, ELISA HEV IGG Tests Type, Rapid Diagnostics Tests Type and Polymerase Chain Reaction Type Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 181: Iran 15-Year Perspective for Hepatitis E Diagnostic Tests by Type - Percentage Breakdown of Value Sales for ELISA HEV IGM Tests Type, ELISA HEV IGG Tests Type, Rapid Diagnostics Tests Type and Polymerase Chain Reaction Type for the Years 2015, 2025 & 2030
    • TABLE 182: Iran Recent Past, Current & Future Analysis for Hepatitis E Diagnostic Tests by End-Use - Hospitals End-Use, Diagnostics Laboratories End-Use, Blood Banks End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Iran Historic Review for Hepatitis E Diagnostic Tests by End-Use - Hospitals End-Use, Diagnostics Laboratories End-Use, Blood Banks End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 184: Iran 15-Year Perspective for Hepatitis E Diagnostic Tests by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostics Laboratories End-Use, Blood Banks End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 185: Israel Recent Past, Current & Future Analysis for Hepatitis E Diagnostic Tests by Type - ELISA HEV IGM Tests Type, ELISA HEV IGG Tests Type, Rapid Diagnostics Tests Type and Polymerase Chain Reaction Type - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Israel Historic Review for Hepatitis E Diagnostic Tests by Type - ELISA HEV IGM Tests Type, ELISA HEV IGG Tests Type, Rapid Diagnostics Tests Type and Polymerase Chain Reaction Type Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 187: Israel 15-Year Perspective for Hepatitis E Diagnostic Tests by Type - Percentage Breakdown of Value Sales for ELISA HEV IGM Tests Type, ELISA HEV IGG Tests Type, Rapid Diagnostics Tests Type and Polymerase Chain Reaction Type for the Years 2015, 2025 & 2030
    • TABLE 188: Israel Recent Past, Current & Future Analysis for Hepatitis E Diagnostic Tests by End-Use - Hospitals End-Use, Diagnostics Laboratories End-Use, Blood Banks End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Israel Historic Review for Hepatitis E Diagnostic Tests by End-Use - Hospitals End-Use, Diagnostics Laboratories End-Use, Blood Banks End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 190: Israel 15-Year Perspective for Hepatitis E Diagnostic Tests by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostics Laboratories End-Use, Blood Banks End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 191: Saudi Arabia Recent Past, Current & Future Analysis for Hepatitis E Diagnostic Tests by Type - ELISA HEV IGM Tests Type, ELISA HEV IGG Tests Type, Rapid Diagnostics Tests Type and Polymerase Chain Reaction Type - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Saudi Arabia Historic Review for Hepatitis E Diagnostic Tests by Type - ELISA HEV IGM Tests Type, ELISA HEV IGG Tests Type, Rapid Diagnostics Tests Type and Polymerase Chain Reaction Type Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 193: Saudi Arabia 15-Year Perspective for Hepatitis E Diagnostic Tests by Type - Percentage Breakdown of Value Sales for ELISA HEV IGM Tests Type, ELISA HEV IGG Tests Type, Rapid Diagnostics Tests Type and Polymerase Chain Reaction Type for the Years 2015, 2025 & 2030
    • TABLE 194: Saudi Arabia Recent Past, Current & Future Analysis for Hepatitis E Diagnostic Tests by End-Use - Hospitals End-Use, Diagnostics Laboratories End-Use, Blood Banks End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Saudi Arabia Historic Review for Hepatitis E Diagnostic Tests by End-Use - Hospitals End-Use, Diagnostics Laboratories End-Use, Blood Banks End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 196: Saudi Arabia 15-Year Perspective for Hepatitis E Diagnostic Tests by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostics Laboratories End-Use, Blood Banks End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 197: UAE Recent Past, Current & Future Analysis for Hepatitis E Diagnostic Tests by Type - ELISA HEV IGM Tests Type, ELISA HEV IGG Tests Type, Rapid Diagnostics Tests Type and Polymerase Chain Reaction Type - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 198: UAE Historic Review for Hepatitis E Diagnostic Tests by Type - ELISA HEV IGM Tests Type, ELISA HEV IGG Tests Type, Rapid Diagnostics Tests Type and Polymerase Chain Reaction Type Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 199: UAE 15-Year Perspective for Hepatitis E Diagnostic Tests by Type - Percentage Breakdown of Value Sales for ELISA HEV IGM Tests Type, ELISA HEV IGG Tests Type, Rapid Diagnostics Tests Type and Polymerase Chain Reaction Type for the Years 2015, 2025 & 2030
    • TABLE 200: UAE Recent Past, Current & Future Analysis for Hepatitis E Diagnostic Tests by End-Use - Hospitals End-Use, Diagnostics Laboratories End-Use, Blood Banks End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 201: UAE Historic Review for Hepatitis E Diagnostic Tests by End-Use - Hospitals End-Use, Diagnostics Laboratories End-Use, Blood Banks End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 202: UAE 15-Year Perspective for Hepatitis E Diagnostic Tests by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostics Laboratories End-Use, Blood Banks End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 203: Rest of Middle East Recent Past, Current & Future Analysis for Hepatitis E Diagnostic Tests by Type - ELISA HEV IGM Tests Type, ELISA HEV IGG Tests Type, Rapid Diagnostics Tests Type and Polymerase Chain Reaction Type - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Rest of Middle East Historic Review for Hepatitis E Diagnostic Tests by Type - ELISA HEV IGM Tests Type, ELISA HEV IGG Tests Type, Rapid Diagnostics Tests Type and Polymerase Chain Reaction Type Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 205: Rest of Middle East 15-Year Perspective for Hepatitis E Diagnostic Tests by Type - Percentage Breakdown of Value Sales for ELISA HEV IGM Tests Type, ELISA HEV IGG Tests Type, Rapid Diagnostics Tests Type and Polymerase Chain Reaction Type for the Years 2015, 2025 & 2030
    • TABLE 206: Rest of Middle East Recent Past, Current & Future Analysis for Hepatitis E Diagnostic Tests by End-Use - Hospitals End-Use, Diagnostics Laboratories End-Use, Blood Banks End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Rest of Middle East Historic Review for Hepatitis E Diagnostic Tests by End-Use - Hospitals End-Use, Diagnostics Laboratories End-Use, Blood Banks End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 208: Rest of Middle East 15-Year Perspective for Hepatitis E Diagnostic Tests by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostics Laboratories End-Use, Blood Banks End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • AFRICA
    • Hepatitis E Diagnostic Tests Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 209: Africa Recent Past, Current & Future Analysis for Hepatitis E Diagnostic Tests by Type - ELISA HEV IGM Tests Type, ELISA HEV IGG Tests Type, Rapid Diagnostics Tests Type and Polymerase Chain Reaction Type - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Africa Historic Review for Hepatitis E Diagnostic Tests by Type - ELISA HEV IGM Tests Type, ELISA HEV IGG Tests Type, Rapid Diagnostics Tests Type and Polymerase Chain Reaction Type Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 211: Africa 15-Year Perspective for Hepatitis E Diagnostic Tests by Type - Percentage Breakdown of Value Sales for ELISA HEV IGM Tests Type, ELISA HEV IGG Tests Type, Rapid Diagnostics Tests Type and Polymerase Chain Reaction Type for the Years 2015, 2025 & 2030
    • TABLE 212: Africa Recent Past, Current & Future Analysis for Hepatitis E Diagnostic Tests by End-Use - Hospitals End-Use, Diagnostics Laboratories End-Use, Blood Banks End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Africa Historic Review for Hepatitis E Diagnostic Tests by End-Use - Hospitals End-Use, Diagnostics Laboratories End-Use, Blood Banks End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 214: Africa 15-Year Perspective for Hepatitis E Diagnostic Tests by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostics Laboratories End-Use, Blood Banks End-Use and Other End-Uses for the Years 2015, 2025 & 2030

IV. COMPETITION